All Things Urticaria – Learning about urticaria with Prof. Dr. Torsten Zuberbier3 Juli 2023

Episode 65 - Audience proposed question: Guidance for potential treatments of CSU

Professor Martin Metz joins Professor Marcus Maurer to answer an audience proposed question focusing on what will guide physicians in the recommendations for individual patients to identify the most beneficial treatment option to treat chronic spontaneous and inducible urticaria. Both experts delve into the current treatment options available, and exciting treatments that are currently in clinical trials. Do you have suggestions for future episodes? Please provide feedback and offer your suggestions for future topics and expert selection here. Utilise the following external links to access additional resources relating to the topics discussed in this episode: Dupilumab in CSU, Remibrutinib in CSU, Bruton's tyrosine kinase inhibition—An emerging therapeutic strategy in immune-mediated dermatological conditions, An open-label, proof-of-concept study of lirentelimab for antihistamine-resistant chronic spontaneous and inducible urticaria, Barzolvolimab in mast cell depletion, Chronic spontaneous urticaria: Focus on pathophysiology to unlock treatment advances, Chronic urticaria and the pathogenic role of mast cells and Urticaria (an overview). Access additional resources by signing up to Medthority and to be notified for future 'All Things Urticaria' podcast episodes! For more information about the UCARE/ACARE network and its activities, please visit: UCARE Website, UCARE LevelUp Program, ACARE Website, UCARE 4U Website, UDAY Website, CRUSE Control App and CURE Registry.

Det här avsnittet är hämtat från ett öppet RSS-flöde och publiceras inte av Podme. Det kan innehålla reklam.

Avsnitt(123)

Urticaria as a Systemic Disease

In this episode of the Global Allergy and Asthma Excellence Network UCARE Podcast on Urticaria, Prof. Torsten Zuberbier speaks with Prof. Marta Ferrer from Spain about an important question: Is chroni...

25 Aug 22min

Disease Modification in Urticaria

In this episode of the UCARE Global Allergy and Asthma Excellence Network (Global Allergy and Asthma Excellence Network) podcast on Urticaria, Prof. Torsten Zuberbier speaks with Prof. Akio Tanaka fro...

21 Juli 16min

AI and the Future of Urticaria

In this episode of the UCARE GA²LEN (Global Allergy and Asthma Excellence Network) podcast on Urticaria, Prof. Torsten Zuberbier and Prof. Hermenio Lima discuss the growing role of artificial intellig...

16 Juni 16min

Urticaria Triggers: Infection Insights

In this episode of the UCARE GA²LEN (Global Allergy and Asthma Excellence Network) podcast on Urticaria, Prof. Torsten Zuberbier and Prof. Maia Gotua discuss the role of infections in acute and chroni...

19 Maj 16min

A New Era in Urticaria Treatment

In this episode of “All Things Urticaria” — a podcast from UCARE, the Global Allergy and Asthma Excellence Network — Prof. Torsten Zuberbier and Prof. Ana Giménez-Arnau discuss the newly released inte...

23 Apr 19min

Managing Urticaria in Resource-Limited Settings

In this episode of the UCARE Global Allergy and Asthma Excellence Network podcast on Urticaria, Prof. Torsten Zuberbier speaks with Dr. Emma Kruger from Cape Town, South Africa, about managing urticar...

24 Mars 17min

Drug Survival of Omalizumab

In this episode of the Urticaria podcast series, Prof. Torsten Zuberbier speaks with Reineke Soegiharto, PhD candidate and dermatology resident from UMC Utrecht, about the international UCARE study DR...

24 Feb 17min

Visualizing Urticaria Worldwide

In this episode of the GA²LEN Urticaria Podcast, Professor Torsten Zuberbier is joined by Professor Simon Francis Thomsen from Denmark to introduce an exciting new global initiative within the UCARE n...

28 Jan 19min